Related Experiment Videos
[Indications for the therapy of chronic lymphatic leukemia]
Deutsche Medizinische Wochenschrift (1946)
|March 20, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.
Annals of oncology : official journal of the European Society for Medical Oncology·2002
Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokinetics.
Cancer chemotherapy and pharmacology·2002
Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2001
[Multiple myeloma as an occupational disease after long-term benzene exposure in a distillery - a case report].
Deutsche medizinische Wochenschrift (1946)·2026
[Chronic Cough].
Deutsche medizinische Wochenschrift (1946)·2026
[Lipid-lowering therapy in transition: implications of the ESC/EAS focused update].
Deutsche medizinische Wochenschrift (1946)·2026
[Re-thinking Organ Donation: Structural development, Multiprofessional Collaboration, and Data-Driven Research].
Deutsche medizinische Wochenschrift (1946)·2026
[Lung Ultrasonography in Intensive Care Medicine].
Deutsche medizinische Wochenschrift (1946)·2026
[Cholangiocarcinoma as a model disease: new pathways in personalized medicine].
Deutsche medizinische Wochenschrift (1946)·2026
Intraoperative Hemodynamic Management and Cerebral Protection During Awake Craniotomy: Evidence-Based Approaches.
Anesthesiology research and practice·2026
Combined Enzyme-Responsive Nano-Peptide Drug with Photothermal Function for Effective Anti-Hepatocellular Carcinoma in Mice Model.
International journal of nanomedicine·2026
Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report.
Journal of hepatocellular carcinoma·2026